Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
649,772
-
Share change
-
+4,644
-
Total reported value
-
$1,694,680
-
Price per share
-
$2.61
-
Number of holders
-
15
-
Value change
-
+$12,132
-
Number of buys
-
8
-
Number of sells
-
1
Institutional Holders of MiNK Therapeutics, Inc. - Stock (INKT) as of Q4 2022
As of 31 Dec 2022,
MiNK Therapeutics, Inc. - Stock (INKT) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
649,772 shares.
The largest 10 holders included
Artal Group S.A., Longbow Finance SA, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, StoneX Group Inc., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and HighTower Advisors, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.